Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma

Jun Shang,He Jiang,Yue Zhao,Jinglei Lai,Leming Shi,Jingcheng Yang,Haiquan Chen,Yuanting Zheng
DOI: https://doi.org/10.1016/j.ebiom.2023.104728
IF: 11.205
2023-07-28
EBioMedicine
Abstract:Summary Background Ground-glass opacity (GGO)-like lung adenocarcinoma (LUAD) has been detected increasingly in the clinic and its inert property and superior survival indicate unique biological characteristics. However, we do not know much about them, which hampers identification of key reasons for the inert property of GGO-like LUAD. Methods Using whole-exome sequencing and RNA sequencing, taking into account both radiological and pathological classifications of the same 197 patients concomitantly, we systematically interrogate genes driving the progression from GGO to solid nodule and potential reasons for the inertia of GGO. Using flow cytometry and IHC, we validated the abundance of immune cells and activity of cell proliferation. Findings Identifying the differences between GGO and solid nodule, we found adenocarcinoma in situ/minimally invasive adenocarcinoma (AIS/MIA) and GGO-like LUAD exhibited lower TP53 mutation frequency and less active cell proliferation-related pathways than solid nodule in LUAD. Identifying the differences in GGO between AIS/MIA and LUAD, we noticed that EGFR mutation frequency and CNV load were significantly higher in LUAD than in AIS/MIA. Regulatory T cell was also higher in LUAD, while CD8+ T cell decreased from AIS/MIA to LUAD. Finally, we constructed a transcriptomic signature to quantify the development from GGO to solid nodule, which was an independent predictor of patients' prognosis in 11 external LUAD datasets. Interpretation Our results provide deeper insights into the indolent nature of GGO and provide a molecular basis for the treatment of GGO-like LUAD. Funding This study was supported in part by the National Natural Science Foundation of China ( 32170657 ), the National Natural Science Foundation of China ( 82203037 ), and Shanghai Sailing Program ( 22YF1408900 ).
medicine, research & experimental
What problem does this paper attempt to address?